Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study

PHASE2CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

November 30, 2005

Conditions
Breast Cancer
Interventions
DRUG

Anastrazole

DRUG

Gefitinib

Trial Locations (34)

Unknown

Research Site, Brno

Research Site, Chomutov

Research Site, Ostrava

Research Site, Ostrava - Poruba

Research Site, Prague

Research Site, Clermont-Ferrand

Research Site, Montpellier

Research Site, Tours

Research Site, Villejuif

Research Site, Budapest

Research Site, Debrecen

Research Site, Kecskemét

Research Site, Coimbra

Research Site, Funchal

Research Site, Lisbon

Research Site, Santiago de Compostela

Research Site, Jaén

Research Site, Seville

Research Site, Valencia

Research Site, Zaragoza

Research Site, A Coruña

Research Site, Gothenburg

Research Site, Mölndal

Research Site, Stockholm

Research Site, Chelmsford

Research Site, Bournemouth

Research Site, Croydon

Research Site, Dundee

Research Site, Leeds

Research Site, Liverpool

Research Site, London

Research Site, Manchester

Research Site, Newcastle upon Tyne

Research Site, Poole

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY